Keywords: UK, Patents Act, Bolar exceptions, Health technology assessment, Clinical trials, BIA, ABPI

UK government moves to cut red tape to benefit R&D for new drugs

Article | 27 February 2013

The UK government yesterday announced a change to the Patents Act which will help the UK's world class life sciences ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in